Welcome to the ISCB Community News Blog

This blog collects news, announcements or other information which could be of interest to our ISCB members. We are a group ISCB members who volunteer to populate this blog on a regular basis. In case you want to become an "ISCB-News Reporter" yourself, let us know: contact ISCB
Don't repost copyrighted content! The guidelines are:
- Include a link to the source page
- Include a short summary about the article. You can quote up to ONE paragraph from the original story, but not more
- Don't repost an entire articles originating from another source
- Never post content without attribution — always include the source

To post a news, please use this form.

Tuesday, May 10, 2016

TransMed 2016: Translational Medicine Informatics & Applications Meeting

ISMB 2016, (Orlando, USA), on July 8, 2016.

Knowledge-based translational medicine is a rapidly growing discipline in biomedical research and aims to expedite the discovery of new diagnostic tools and treatments by using a multi-disciplinary, highly collaborative, "bench-to-bedside" approach. Large amounts of multi-omics, imaging (medical and molecular) and clinical data can now be captured for given patient populations. In addition to the challenges of data curation and harmonisation, new computational methods are required to identify molecular signatures that suggest disease subtype. These signatures may be predictive of outcome or progression, and impact on disease management by suggesting personalised therapeutic strategies for patients. Such approaches will further the development of a new taxonomy of disease.

In the TransMed SIG meeting, we will explore the current status of computational biology approaches within the field of translational medicine.

Keynote Speakers Confirmed:

Prof. Russ Altman, Professor of Bioengineering, Genetics, Medicine and Computer Science; Director, Biomedical Informatics Training Program, School of Medicine, Stanford University

Prof. Sean Mooney, Professor of Biomedical Informatics and Medical Education, University of Washington; Chief Research Information Officer (CRIO) of UW Medicine

Prof. John Overington, Director of Bioinformatics at Stratified Medical, Visiting Professor at the Institute of Cardiovascular Science, University College London and the Farr Institute

Key dates:

Abstract submissions deadline: May 15, 2016

Poster and Presentation acceptance notifications: May 22, 2016

Final program available: May 31, 2016

TransMed 2016 SIG: July 8, 2016

URL: http://transmedit.org/Main_Page

Contact Person: TransMed (transmed-coord@googlegroups.com)

Announcing the May launch of the Respiratory Viral DREAM Challenge

Announcing the May launch of the Respiratory Viral DREAM Challenge

The First of the DREAM11 Challenges

Dear DREAM Community,

Mark your calendars! We are pleased to announce that the first Challenge of the DREAM11 season will be launching soon on May 15th.

The Respiratory Viral DREAM Challenge: Discovering dynamic molecular signatures in response to viral exposure will launch on May 15 and run through September 2016. To register go to http://www.http.com/www.synapse.org/ViralChallenge.

This Challenge will assess current capabilities to predict rate and severity of infection following exposure to respiratory viruses. Analysis will focus on gene expression array data collected by our partners at Duke University in a longitudinal manner from healthy volunteers exposed to respiratory viruses.

This is an exciting opportunity for DREAMers to develop methodologies for dynamic modeling based on time series data. Participants will be invited to discuss the results of this Challenge with clinical experts in a one-day workshop at the completion of the Challenge. Winners will also be invited to join in the development of a journal article describing these results and to present at the annual DREAM Conference taking place this November.

For more information and to register for this Challenge, please visit the challenge website at: http/www.synapse.org/ViralChallenge


URL: http/www.synapse.org/ViralChallenge

Contact Person: Gustavo Stolovitzky (gustavo@us.ibm.com)

Friday, May 6, 2016

Senate Appropriations Hearing

Dr. Collins and Institute Directors Drs. Christopher Austin, NCATS; Richard Hodes, NIA; Walter Koroshetz, NINDS; Douglas Lowy, NCI; and Nora Volkow, NIDA testified earlier this month before the Senate L-HHS subcommittee on NIH's FY17 budget request. Dr. Collins and members of the Subcommittee noted with emotion that this may be Dr. Collins' last appropriations hearing (see 2:11:20). For those who missed the live event, you can still view the webcast (http://www.appropriations.senate.gov/hearings/hearing-on-fy2017-national-institutes-of-health-budget-request) and read Dr. Collins' written testimony (https://www.nih.gov/about-nih/who-we-are/nih-director/testimony-fiscal-year-2017-budget-request-before-senate-committee)
URL: https://www.nih.gov/

Contact Person: NIH (NIHOutreachOffice@od.nih.gov)

April Visitors to NIH

April has seen several Congressional members visit NIH. Most recently, Representative Robert Dold and four colleagues, Representatives Susan Brooks, Katherine Clark, Joseph Kennedy, and David Valadao, met with NIH leadership and toured three labs, hearing updates about immunotherapy approaches in cancer treatments, therapies for diabetes and metabolic disorders, and surgical interventions for epilepsy patients. Earlier in the month, Representative Pete Sessions came out to attend a scientific meeting hosted by the National Eye Institute, Representative Barbara Comstock toured two labs, and Senator Barbara Mikulski met with NIH leadership and spoke at a town hall with NIH staff.

Maryland Governor Larry Hogan visited last week. He met with Dr. Louis Staudt of NCI, toured the Children's Inn, and spoke with several patients. Mr. Hogan, a cancer survivor himself, shared how his experiences have given him a new appreciation for medical research and offered his support for NIH's work.
URL: https://www.nih.gov/

Contact Person: NIH (NIHOutreachOffice@od.nih.gov)

Share Your Ideas for the Cancer Moonshot

The National Cancer Institute (NCI) has launched the Cancer Research Ideas (https://cancerresearchideas.cancer.gov/) online platform to collect community input to inform the National Cancer Moonshot Initiative. We hope to hear from a broad cross-section of the community, including researchers, advocates, philanthropists, data scientists, and members of the public, about their ideas for speeding up scientific advances in cancer research and spurring progress in prevention, treatment, and care. Visit the website by July 1 to submit your ideas or comment on the submissions we've already received. And please help us spread the word to your colleagues and communities and encourage them to share their ideas as well.

Plans are underway for a Cancer Moonshot Summit later this year. The summit will be a forum for updates on the Initiative and dialogue.
URL: https://cancerresearchideas.cancer.gov/

Contact Person: NIH (NIHOutreachOffice@od.nih.gov)

Dr. Collins Appoints PMI, ECHO Directors

Earlier this month, NIH Director Dr. Francis Collins announced the appointment of Eric Dishman as Director of the Precision Medicine Initiative (PMI) Cohort Program. Mr. Dishman, who will be stepping down from his role as Vice President and Fellow at Intel's Health & Life Sciences Group to move to NIH in June, will lead NIH's effort to build the PMI landmark longitudinal research study of one million or more U.S. volunteers. He brings not just a wealth of knowledge as a social scientist, researcher, and business leader, but also personal experience as a patient and patient advocate. For more details, you can read Dr. Collins' statement about the appointment and Mr. Dishman's interview with ScienceInsider where he discusses his motivation, vision, and the challenges he foresees. https://www.nih.gov/about-nih/who-we-are/nih-director/statements/selection-eric-dishman-director-precision-medicine-initiative-cohort-program

Dr. Collins this month also appointed Matthew Gillman, M.D., as Environmental Influences on Child Health Outcomes (ECHO) Program Director. ECHO is a seven-year NIH initiative to use large, existing study cohorts to conduct research on high-impact pediatric health outcomes. Please see Dr. Collins' statement for more information. https://www.nih.gov/about-nih/who-we-are/nih-director/statements/selection-dr-matthew-gillman-echo-program-director
URL: https://www.nih.gov/

Contact Person: NIH (NIHOutreachOffice@od.nih.gov)